ACTRN12619000870156
Completed
未知
Transcranial alternating current stimulation for apathy in Huntington's disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Huntington's disease
- Sponsor
- Monash University
- Enrollment
- 44
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Individuals with genetically confirmed prodromal or early stage HD, as well as individuals without HD matched for age, gender and education will be sought as participants.
- •\-Participants with prodromal HD will need to be within approximately 12 years of expected motor onset or have a disease burden score” (DBS) of at least 280, indices calculated using the prospective participant’s current age and number of CAG repeats on the affected allele.
- •\-Participants with early stage manifest HD will need to have a total functional capacity (TFC) score greater than, or equal to 10 . The TFC is used to assess how much assistance a person with HD requires to perform tasks in five functional domains that decline with disease progression (i.e., occupation, finances, domestic chores, activities of daily living, and care level).
Exclusion Criteria
- •\- Use of anticonvulsant medications or regular treatment with benzodiazepines (versus limited as\-needed use, with none consumed within the 48 hours prior to an experimental session).
- •\-Commencement or significant dosage alteration of other psychotropic medications (i.e., anti\-depressants, anti\-psychotics) during the four weeks prior to an experimental session.
- •\-Choreiform movements that preclude tACS or EEG data collection.
- •\-A current episode of psychiatric illness, or a current substance use or alcohol use disorder, initially assessed via the recruitment screen, and then as assessed and defined by the Mini International Neuropsychiatric Interview (MINI) 7\.0\.2\.
- •\-Any history of significant head injury or traumatic brain injury, as defined by a loss of consciousness greater than 30 minutes or requiring a hospital admission.
- •\-Unstable medical illness.
- •\-Pregnancy or breastfeeding.
- •\-An uncorrected hearing or visual impairment (including difficulty with colour perception).
- •\-Significant difficulties with understanding or communicating in English.
- •\-Metallic implants within the head, a pacemaker, cochlear implant, medication pump or other electronic device within the body.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
Transcranial alternating current stimulation of the auditory system in patients with tinnitus and healthy controlsH93.1H91TinnitusOther hearing lossDRKS00033120Abteiliung für Hals-Nasen-Ohren-Heilkunde, Fakultät VI für Medizin und Gesundheitswissenschaften, Carl von Ossietzky Universität Oldenburg40
Completed
Not Applicable
Transcranial alternating current stimulation and its influences on neurophysiological mechanisms of error processing and error regulation in healthy subjects and patients with attention deficit hyperactivity disorder (ADHD)Healthy SubjectsF90.0Disturbance of activity and attentionDRKS00008209Institut für Medizinische Psychologie und Medizinische SoziologieUniversitätsklinikum Schleswig-Holstein50
Completed
Not Applicable
Transcranial alternating current stimulation and error information modulate the motor cortex-evoked activity and behaviorJPRN-UMIN000027935Tokyo Kasei University20
Completed
Not Applicable
Transcranial Alternating Current Stimulation (tACS) as a novel treatment option: a proof of concept study in Adult Classic GalactosemiaNL-OMON49032Medisch Universitair Ziekenhuis Maastricht50
Completed
Not Applicable
Transcranial Alternating Current Stimulation (tACS) as a Tool to Modulate P300 Amplitude in Attention Deficit Hyperactivity Disorder (ADHD)F90.0Disturbance of activity and attentionDRKS00010907Department of Psychology, European Medical SchoolCarl von Ossietzky Universität18